InvestorsHub Logo
Followers 30
Posts 2791
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Sunday, 08/28/2022 2:30:22 PM

Sunday, August 28, 2022 2:30:22 PM

Post# of 381
(OT) New preclinical data on ONKT102, an anti-CD38 CAR-NK cell product for R/R multiple myeloma https://www.onktherapeutics.com/wp/wp-content/uploads/2022/08/ONK-poster-IMS2022.pdf

It will have additional modifications, which are CISH knockout, and possibly a DR5-specific TRAIL variant. Also, they will add an (systemic) anti-IL-6R mAb https://www.sciencedirect.com/science/article/abs/pii/S1040842816301627 https://www.frontiersin.org/articles/10.3389/fendo.2018.00788/full
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News